Study of APR-1051 in Patients With Advanced Solid Tumors
Study of APR-1051 in Patients With Advanced Solid Tumors
Recruiting · NCT06260514 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of APR-1051 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2026-10-09 | NCT06260514 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aprea Therapeutics | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center (MDACC) | Houston | United States | 2 |
| NEXT Oncology -Dallas | Irving | United States | 1 |
| NEXT Oncology -San Antonio | San Antonio | United States | 1 |
| NEXT Oncology -Virginia | Fairfax | United States | 2 |
| NEXT Oncology- Houston | Houston | United States | 1 |
| Rutgers Cancer Institute | New Brunswick | United States | 6 |
| University Hospitals, Cleveland Medical Center | Cleveland | United States | 5 |